Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Time BioVentures is a venture capital firm specializing in life sciences and healthcare, established in 2020 in Los Angeles, California. The firm focuses on financing entrepreneurs who are developing innovative technologies aimed at improving patient care and extending life. Time BioVentures has a notable scientific advisory board that includes Nobel laureates, enhancing its credibility and ability to support groundbreaking advancements in healthcare.
Currently, Time BioVentures manages a portfolio of 21 companies and has a team of 15 professionals, including three partners. The firm primarily invests in early-stage companies, with a focus on pre-seed, seed, seed-plus, and Series A funding rounds. Time BioVentures has established itself as a significant player in the healthcare venture capital space, with a mission to back entrepreneurs who are creating transformative medical products and technologies.
Time BioVentures invests across various sectors within the life sciences, including therapeutics, diagnostics, research tools, medical devices, and care delivery. The firm targets early-stage investments, specifically in pre-seed, seed, seed-plus, and Series A rounds. Their investment strategy emphasizes supporting companies that are developing groundbreaking medical products and technologies that can significantly improve patient outcomes and longevity.
The firm looks for entrepreneurs who are passionate about their innovations and have a clear vision for how their technologies can impact healthcare. Time BioVentures prefers to engage with startups that demonstrate a strong potential for growth and scalability, particularly those that align with their mission of enhancing patient care. The firm also values strategic partnerships and co-investment opportunities that can further amplify the impact of their portfolio companies.
Time BioVentures has a diverse portfolio of 21 companies, showcasing its commitment to advancing healthcare technologies. Notable portfolio companies include:
This portfolio reflects Time BioVentures' focus on innovative solutions that address critical healthcare challenges and improve patient outcomes.
D.A. Wallach - General Partner; previously an acclaimed recording artist and recognized as one of Fast Company's 100 Most Creative People in Business.
Tim Wright, M.D. - General Partner; brings extensive experience in healthcare investments and innovation.
Ryan Moriarty - Associate; focuses on sourcing and evaluating investment opportunities within the life sciences sector.
Pam Sharma, M.D., Ph.D. - Scientific Advisor; a professor at MD Anderson Cancer Center specializing in genitourinary oncology and immunology.
Jim Allison, Ph.D. - Scientific Advisor; Nobel Prize winner in 2018 for his work in cancer immunotherapy.
Sarkis Mazmanian, Ph.D. - Scientific Advisor; recognized for his research in microbiome and its impact on health.
Peter Attia, M.D. - Scientific Advisor; a longevity physician and host of The Drive podcast, trained at Stanford and Johns Hopkins.
Paul McEwan - Scientific Advisor; provides insights into drug development and commercialization strategies.
Bradford Cornell - Advisor; brings expertise in finance and investment strategies.
Robert Nelsen - Advisor; co-founder of ARCH Venture Partners with a focus on biotechnology.
Sean Parker - Advisor; known for his role in founding Napster and his investments in healthcare.
Leonard Schaeffer - Advisor; former CEO of WellPoint and a leader in healthcare management.
Jay Flatley - Advisor; former CEO of Illumina, contributing expertise in genomics.
Daniel L. Vasella, M.D. - Advisor; former CEO of Novartis, with extensive experience in pharmaceuticals.
To pitch to Time BioVentures, founders should visit their website at timebioventures.com. It is recommended to include a comprehensive business plan, details about the technology, and its potential impact on healthcare in the pitch deck. The firm values clear communication and a well-defined vision.
Response times may vary, but founders should expect to hear back within a few weeks after submission. Warm introductions are preferred, as they can enhance the likelihood of a favorable review.
As of March 2026, Time BioVentures has made significant strides in the healthcare venture capital space. The firm has successfully invested in 21 companies, including notable names like Neuralink and Iterative Health. Their portfolio reflects a strong commitment to supporting innovative healthcare solutions.
In recent months, Time BioVentures has been actively seeking new investment opportunities in the biotech sector, focusing on companies that align with their mission of improving patient outcomes. The firm continues to expand its network of industry experts and advisors to enhance the support provided to its portfolio companies.
What are Time BioVentures' investment criteria?
Time BioVentures invests in early-stage companies within the life sciences sector, focusing on therapeutics, diagnostics, medical devices, and care delivery. They seek entrepreneurs developing innovative technologies that can significantly enhance patient care and longevity.
How can I apply or pitch to Time BioVentures?
Founders can pitch their ideas through the Time BioVentures website at timebioventures.com. It is advisable to include a detailed business plan and information about the technology and its potential impact on healthcare.
What makes Time BioVentures different from other venture capital firms?
Time BioVentures distinguishes itself through its marquee scientific advisory board, which includes Nobel laureates and industry experts. This board provides strategic guidance and insights that can significantly benefit portfolio companies.
What is the geographic scope of Time BioVentures' investments?
The firm primarily focuses on investments in North America, targeting innovative healthcare startups that align with their mission.
What is the typical check size for investments?
Time BioVentures typically invests in pre-seed, seed, seed-plus, and Series A rounds, with check sizes varying based on the stage and needs of the startup.
What kind of post-investment involvement does Time BioVentures have?
Time BioVentures provides operational support, strategic guidance, and access to a network of industry experts to help portfolio companies navigate the complexities of the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.